WHO prequalifies new HPV single-dose vaccine: Know all about it

Posted on:
Key Points

The WHO has prequalified Cecolin, a new HPV vaccine developed in China, for single-dose use...

The World Health Organisation has prequalified a new human papillomavirus (HPV) vaccine, Cecolin, that can be used in a single-dose schedule...

This is the fourth HPV vaccine to receive such approval, based on recent data that meets WHO's 2022 guidelines for using HPV vaccines in one dose...

Its prequalification means that there are more vaccines in the market to help fight against cervical cancer, especially in regions facing vaccine shortages, allowing more girls to receive protection...

Dr Kate O'Brien, Director of WHOs Department of Immunisation, said that the introduction of single-dose vaccines will provide countries with more options and help them reach more girls despite ongoing supply challenges...

You might be interested in

Why govt has no plans to include cervical cancer vaccine in routine immunisation package anytime soon

08, Feb, 24

Health ministry officials say plan to bring it under nation’s Universal Immunisation Programme stays shelved, mainly due to reasons related to funds and concern around side-effects.

This Vaccine Protects Against Cancer—but Not Enough Boys Are Getting It

20, Oct, 23

The HPV vaccine can effectively prevent a range of cancers if administered at the right age. But boys still can't access it in most countries.

Cervarix to Cervavac: A look at cervical cancer vaccines available in India & how much they cost

13, Feb, 24

During interim budget speech, Finance Minister Nirmala Sitharaman said govt would encourage vaccination against HPV. Experts call for including it in Universal Immunisation Programme.

Centre to encourage HPV vaccination for cervical cancer through price capping: Report

02, Feb, 24

The Centre, which announced plans to encourage vaccinations against the human papilloma virus (HPV) through its immunisation programme, is exploring options to cap prices so that the vaccines to treat cervical cancer become more affordable, according to a report, citing official sources

Scottish study finds zero cases of cervical cancer among women vaccinated against HPV at 12-13 yrs

24, Jan, 24

Study conducted by Public Health Scotland in collaboration with University of Strathclyde & University of Edinburgh. Findings published in Journal of the National Cancer Institute.

All you need to know about HPV vaccine: Who needs it, how does it work

15, Jan, 24

The HPV vaccine, regular screening and pre-cancer treatment can help manage cervical cancer, which is the second-biggest killer of women in India.